BPG is committed to discovery and dissemination of knowledge
Basic Study
Copyright: ©Author(s) 2026.
World J Stem Cells. Oct 26, 2026; 18(10): 122760
Published online Oct 26, 2026. doi: 10.4252/wjsc.122760
Figure 4
Figure 4 Alterations in pancreatic metabolites and metabolic pathways induced by human umbilical cord mesenchymal stem cells in a rat model of diabetes. A: Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment bubble plot depicting differential metabolites between diabetes mellitus (DM) and control rats; B: KEGG enrichment analysis of metabolites differentially expressed after human umbilical cord mesenchymal stem cell intervention relative to the diabetic control group, presented as a bubble plot; C: Venn diagram illustrating key differential metabolites (KDMs) across the indicated group comparisons; D: Heatmap depicting 30 KDMs; E: KEGG enrichment bubble plot for the 30 KDMs. Control, n = 8; DM, n = 6; DM + human umbilical cord mesenchymal stem cells, n = 5. KEGG: Kyoto Encyclopedia of Genes and Genomes; DM: Diabetes mellitus; hUC-MSCs: Human umbilical cord mesenchymal stem cells; PPAR: Peroxisome proliferator-activated receptor.


Write to the Help Desk